Viewing Study NCT00036166



Ignite Creation Date: 2024-05-05 @ 11:25 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00036166
Status: COMPLETED
Last Update Posted: 2018-01-10
First Post: 2002-05-08

Brief Title: Study of FK463 for the Treatment of Invasive Aspergillosis
Sponsor: Astellas Pharma Inc
Organization: Astellas Pharma Inc

Study Overview

Official Title: An Open-Label Non-Comparative Study of FK463 for the Treatment of Invasive Aspergillosis
Status: COMPLETED
Status Verified Date: 2015-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of the study is to evaluate the safety and efficacy of FK463 in patients with proven or probable invasive infections due to Aspergillus species
Detailed Description: This will be an open-label non-comparative study of intravenous FK463 Enrollment will include at least 100 patients evaluable for efficacy

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
98-0-046 OTHER Alternate Protocol Number None